Chiu, Pai-Yi <br/><br/>
Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study.  [electronic resource] 

 -  Clinical drug investigation  2009 
 - 729-38 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1173-2563 
<br/><br/><label>Standard No.: </label>10.2165/11315320-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alzheimer Disease--drug therapy<br/>Cholinesterase Inhibitors--therapeutic use<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Patient Satisfaction<br/>Phenylcarbamates--adverse effects<br/>Product Surveillance, Postmarketing<br/>Rivastigmine